A Phase II, Open Label, Single-Arm Study on the Efficacy of Cabozantinib in Patients With Advanced/Metastatic Nonsmall Cell Lung Cancer Harboring MET Exon 14 Alterations who Developed Acquired Resistance to Tepotinib or Capmatinib (CAPTURE Trial)
用户cLCxSEj5otc4
1个月前
77
10
已完结
1. 系统已在2025-09-01 17:35:50对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1016/j.cllc.2024.12.004
文献链接: https://linkinghub.elsevier.com/retrieve/pii/S1525730424002675
其他信息:
出版社: Elsevier BV
作者: Masayuki Takeda; Masahide Ota; Eiji Iwama; Shunichi Sugawara; Takehito Shukuya; Shigeki Umemura; Hiroshi Tanaka; Masahide Oki; Takayuki Takahama; Takeshi Masuda; Naoyuki Nogami; Mototsugu Shimokawa
